National Vaccine And Serum Institute, China

This large, completed study tested a new vaccine designed to protect children from norovirus, a very common cause of stomach flu. It involved 8,000 healthy children aged 6 months to 13 years. The main goal was to see if the vaccine safely prevents moderate to severe vomiting and …

This early-stage study tested the safety and immune response of a new COVID-19 vaccine called GEN2 in 234 healthy adults. Researchers gave different versions of the vaccine to volunteers aged 18 and older to check for side effects and measure how well it triggered protective anti…

This study tested a new COVID-19 vaccine to see if it was safe and if it triggered a protective immune response. It involved 3,100 healthy volunteers, including children as young as 3 and adults up to age 70 and older. Researchers compared different doses and schedules to find th…